Citations to this article

Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie, William Pao, Noriko Motoi, William L. Gerald, William D. Travis, William Bornmann, Darren Veach, Bayard Clarkson, Jacqueline F. Bromberg
Published in Volume 117, Issue 12
J Clin Invest. 2007; 117(12):3846–3856 doi:10.1172/JCI31871

Total citations by year

Year: 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 25 33 34 28 26 32 15 1 194
Citation information

Citations to this article in year 2009 (32)

Title and authors Publication Year
Immune Therapy for Cancer
M Dougan, G Dranoff
Annual Review of Immunology 2009
Ikappa B kinaseβ/nuclear factor-κB activation controls the development of liver metastasis by way of interleukin-6 expression
S Maeda, Y Hikiba, K Sakamoto, H Nakagawa, Y Hirata, Y Hayakawa, A Yanai, K Ogura, M Karin, M Omata
Hepatology 2009
IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors
R Rosell, J Bertran-Alamillo, MA Molina, M Taron
Future Oncology 2009
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
M Hedvat, D Huszar, A Herrmann, JM Gozgit, A Schroeder, A Sheehy, R Buettner, D Proia, CM Kowolik, H Xin, B Armstrong, G Bebernitz, S Weng, L Wang, M Ye, K McEachern, H Chen, D Morosini, K Bell, M Alimzhanov, S Ioannidis, P McCoon, ZA Cao, H Yu, R Jove, M Zinda
Cancer Cell 2009
A component of polysaccharide peptidoglycan complex onLactobacillusinduced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer
S Matsumoto, T Hara, M Nagaoka, A Mike, K Mitsuyama, T Sako, M Yamamoto, S Kado, T Takada
Immunology 2009
Janus Kinase Mutations
RL Levine
Seminars in Oncology 2009
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
A Saidi, M Hagedorn, N Allain, C Verpelli, C Sala, L Bello, A Bikfalvi, S Javerzat
International Journal of Cancer 2009
STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria
L Samavati, R Rastogi, W Du, M Hüttemann, A Fite, L Franchi
Molecular Immunology 2009
STATs in cancer inflammation and immunity: a leading role for STAT3
H Yu, D Pardoll, R Jove
Nature Reviews Cancer 2009
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
F Colotta, P Allavena, A Sica, C Garlanda, A Mantovani
Carcinogenesis 2009
Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling
J Inokuchi, A Lau, DR Tyson, DK Ornstein
Carcinogenesis 2009
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
DJ Gough, A Corlett, K Schlessinger, J Wegrzyn, AC Larner, DE Levy
Science 2009
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression
YP Luo, H Zhou, J Krueger, C Kaplan, D Liao, D Markowitz, C Liu, T Chen, TH Chuang, R Xiang, RA Reisfeld
Oncogene 2009
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
M Walter, S Liang, S Ghosh, PJ Hornsby, R Li
Oncogene 2009
Serum levels of nicotinamide N-methyltransferase in patients with lung cancer
M Tomida, I Mikami, S Takeuchi, H Nishimura, H Akiyama
Journal of Cancer Research and Clinical Oncology 2009
Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
K Komiya, N Sueoka-Aragane, A Sato, T Hisatomi, T Sakuragi, M Mitsuoka, T Sato, S Hayashi, H Izumi, M Tsuneoka, E Sueoka
Journal of Cancer Research and Clinical Oncology 2009
Activation of Stat3 in renal tumors
C Guo, G Yang, K Khun, X Kong, D Levy, P Lee, J Melamed
American journal of translational research 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
S Veeriah, C Brennan, S Meng, B Singh, JA Fagin, DB Solit, PB Paty, D Rohle, I Vivanco, J Chmielecki, W Pao, M Ladanyi, WL Gerald, L Liau, TC Cloughesy, PS Mischel, C Sander, B Taylor, N Schultz, J Major, A Heguy, F Fang, IK Mellinghoff, TA Chan
Proceedings of the National Academy of Sciences of the United States of America 2009
The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells
BD Adams, DM Cowee, BA White
Molecular endocrinology (Baltimore, Md.) 2009
Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells
H Xin, C Zhang, A Herrmann, Y Du, R Figlin, H Yu
Cancer research 2009
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer
S Grivennikov, E Karin, J Terzic, D Mucida, GY Yu, S Vallabhapurapu, J Scheller, S Rose-John, H Cheroutre, L Eckmann, M Karin
Cancer Cell 2009
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease
P Qu, J Roberts, Y Li, M Albrecht, OW Cummings, JN Eble, H Du, C Yan
Lung cancer (Amsterdam, Netherlands) 2009
Therapeutic targeting of myeloid-derived suppressor cells
S Ugel, F Delpozzo, G Desantis, F Papalini, F Simonato, N Sonda, S Zilio, V Bronte
Current Opinion in Pharmacology 2009
ErbB receptors and signaling pathways in cancer
NE Hynes, G MacDonald
Current Opinion in Cell Biology 2009
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
J Bollrath, TJ Phesse, VA von Burstin, T Putoczki, M Bennecke, T Bateman, T Nebelsiek, T Lundgren-May, Ö Canli, S Schwitalla, V Matthews, RM Schmid, T Kirchner, MC Arkan, M Ernst, FR Greten
Cancer Cell 2009